Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure ...

Bayer seeks European marketing approval for use of finerenone in adult patients with HF with a left ventricular ejection fraction (LVEF) of =40%: Berlin Tuesday, February 4, 2025, ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...

Out of necessity, then, the National Socialists had to derive most of their financing via membership fees, storm troopers ...

Israeli pharmaceutical company RedHill Biopharma has initiated a placebo-controlled Phase II trial to assess the combination ...

A free trade agreement (FTA) with the EU is a top priority for the Thai government, while businesses on both sides support a ...

A new bill introduced in the Iowa Senate looks to ensure consistency in the labeling of products reviewed by the ...

Q4 2024 Earnings Call Transcript February 4, 2025 Dassault Systèmes SE beats earnings expectations. Reported EPS is $0.43, ...

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word (s): AGM/EGM SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items 04.02.2025 / 18:22 CET/CEST The issuer is ...

Frequent explosions plagued the U.S. grain industry until the Occupational Safety and Health Administration introduced new ...